Immuno-oncology has emerged over the past decade as an important approach to cancer treatment. It aims to stimulate the patient’s immune system by enhancing its natural ability to fight disease.
At Seqalis™, we have developed a unique solution for the analysis of the T-cell receptor (TCRseq) immune repertoire.